Table 6. Association between the 18-gene signature score and response to treatment (mean signature score is given).
Response | ||||||
GSE22358 (N = 154) | Neoadjuvant chemotherapy | Chemotherapy + trastuzumab | ||||
npCR1/pCR2 | NR3/PR4 | p-value5 | npCR/pCR | NR/PR | p-value5 | |
3.25 | −1.15 | 0.017 | 3.17 | −0.12 | 0.089 | |
GSE20271 (N = 178) | FAC treated | T/FAC treated | ||||
pCR | RD6 | p-value | pCR | RD | p-value | |
0.10 | 0.21 | NS | −0.26 | −0.02 | NS | |
GSE 20194 (N = 230) | Neoadjuvant chemotherapy | |||||
pCR | RD | p-value | ||||
2.18 | −0.55 | <0.001 |
Near-complete pathologic response,
Pathologic complete response,
No response,
Partial respons,
Mann-Whitney U test,
Residual disease.